Distribution of (a) male and (b) female CD cases, and (c) male and (d) female UC cases, normalised by population across the UK.

Distribution of (a) male and (b) female CD cases, and (c) male and (d) female UC cases, normalised by population across the UK.

<p>Distribution of (a) male and (b) female CD cases, and (c) male and (d) female UC cases, normalised by population across the UK.</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Mehmet A. Veral (22138919) (author)
Eará dahkkit:	Roger W. Pickup (3258201) (author), Manoj Roy (19283185) (author), Jeremy Sanderson (652025) (author), Gaurav Agrawal (18236244) (author), Peter M. Atkinson (11797781) (author)
Almmustuhtton:	2025
Fáttát:	Medicine Biotechnology Ecology Immunology Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified two main forms possible sampling biases participants &# 8217 crohn &# 8217 20 &# 8211 03 oct 2022 even geographical distribution standardized morbidity rates reported morbidity rate uc predominately affects relative risk across inflammatory bowel disease asmr analysis revealed 59 age range reported ibd cases morbidity rate relative risk prevalence rates geographic distribution uc cases ibd cases west england ulcerative colitis uc ratio uc ). study reports promoted periodically much higher may require large values involving 5 increasing worldwide ibd diagnoses grid scale digestive system collected data chronic inflammation 452 respondents 307 days
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid

Distribution of IBD cases normalised by population across the UK according to the postcode at first diagnosis: (a) CD, (b) UC and (c) all IBD cases.
Dahkki: Mehmet A. Veral (22138919)
Almmustuhtton: (2025)

Distribution of CD:UC ratio for each grid square across the UK.
Dahkki: Mehmet A. Veral (22138919)
Almmustuhtton: (2025)

ASMR for CD and UC by gender plotted against age, represented in eight age categories.
Dahkki: Mehmet A. Veral (22138919)
Almmustuhtton: (2025)

Age-gender, case, risk and population distribution data per grid.
Dahkki: Mehmet A. Veral (22138919)
Almmustuhtton: (2025)

Crude incidence rate (per 100,000) of IBD overall, CD, and UC in North of China.
Dahkki: Hong Yang (37298)
Almmustuhtton: (2014)

Age-standardized incidence rate (per 100,000) of IBD overall, CD, and UC in North of China.
Dahkki: Hong Yang (37298)
Almmustuhtton: (2014)

Clinical characteristics of UC and CD patients in the case-series of patients in Mexico City (n = 200) and Bogota (n = 204).
Dahkki: Agustín Ciapponi (202565)
Almmustuhtton: (2020)

Multivariate logistic regression results for UC patients.
Dahkki: Aimee Hiller (6650687)
Almmustuhtton: (2019)

Supplementary Material for DDW 2025 Scientific Presentations
Dahkki: Marc Fellmann (10811705)
Almmustuhtton: (2025)

Latency months in 3 age groups using boxplots and separated by diagnosis: Crohn’s Disease (CD) and Ulcerative Colitis (UC).
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)

Clinical associations of UC/IBDU patients with ankylosing spondilitis / sacroliitis.
Dahkki: Aimee Hiller (6650687)
Almmustuhtton: (2019)

Treatment history and appearance of joint manifestations in UC/IBDU patients.
Dahkki: Aimee Hiller (6650687)
Almmustuhtton: (2019)

Forest plot of the association between BMI and UC.
Dahkki: Jie Dong (12143)
Almmustuhtton: (2015)

Prevalence ratio of selected clinical manifestations in UC versus CD patients, by country (2018).
Dahkki: Agustín Ciapponi (202565)
Almmustuhtton: (2020)

Relation between epidemiological factors and the presence of joint EIM in UC/IBDU patients.
Dahkki: Aimee Hiller (6650687)
Almmustuhtton: (2019)

Results of the incidence trend analysis of Inflammatory Bowel Disease (IBD), Crohn’s Disease (CD), Ulcerative Colitis (UC) and unclassified IBD (IBD-U) for all patients and separately by gender using joinpoint regression.
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)

Forest plot of subgroup analysis of BMI in UC patients in active or remission phase.
Dahkki: Jie Dong (12143)
Almmustuhtton: (2015)

Forest plot of subgroup analysis of BMI in UC patients with or without medicine therapy.
Dahkki: Jie Dong (12143)
Almmustuhtton: (2015)

Results of the age trend analysis of Inflammatory Bowel Disease (IBD), Crohn’s Disease (CD), Ulcerative Colitis (UC) and unclassified IBD (IBD-U) using linear regression with trend lines y = a*x+b.
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)

Disease characteristics (disease location, disease activity), disease complications and other EIMs in relation to joint EIM in UC/IBDU patients.
Dahkki: Aimee Hiller (6650687)
Almmustuhtton: (2019)

Comparison of complete population prevalence and incidence rates of UC and CD as modelled by DisMod II and MIAMOD for Colombia in the years 2010 and 2015/6, and from SISPRO.
Dahkki: Agustín Ciapponi (202565)
Almmustuhtton: (2020)

Age-standardized incidence rates (ASR) of Inflammatory Bowel Disease (IBD), Crohn’s Disease (CD), Ulcerative Colitis (UC) and unclassified IBD (IBD-U) per 100,000 Person-Years (PY) for children and adolescents < 15 years of age at diagnosis in Saxony.
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)

Clinical signs and symptoms observed in IBD case-series of patients in both countries.
Dahkki: Agustín Ciapponi (202565)
Almmustuhtton: (2020)

Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study
Dahkki: Agustín Ciapponi (202565)
Almmustuhtton: (2020)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs) - Fig 1
Dahkki: Zahava Vadasz (740010)
Almmustuhtton: (2015)

Clinical correlation.
Dahkki: Zahava Vadasz (740010)
Almmustuhtton: (2015)

Serum levels of sema4A.
Dahkki: Zahava Vadasz (740010)
Almmustuhtton: (2015)

Sema3A staining in IBD.
Dahkki: Zahava Vadasz (740010)
Almmustuhtton: (2015)

Immunohistochemistry staining of sema4A.
Dahkki: Zahava Vadasz (740010)
Almmustuhtton: (2015)

Clinical characteristics of Crohn’s disease patients.
Dahkki: Zahava Vadasz (740010)
Almmustuhtton: (2015)

Ulcerative Colitis: Major DRG categories sorted by case frequency and stratified by cost weight (CW) and coverage.
Dahkki: Daniel C. Baumgart (846351)
Almmustuhtton: (2016)

Crohn’s Disease: Major DRG categories sorted by case frequency and stratified by cost weight (CW) and coverage.
Dahkki: Daniel C. Baumgart (846351)
Almmustuhtton: (2016)

Galectin levels in patients with active and inactive UC.
Dahkki: Tony B. Yu (8292684)
Almmustuhtton: (2020)

Galectin levels in healthy controls, UC and CD patients.
Dahkki: Tony B. Yu (8292684)
Almmustuhtton: (2020)

The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds
Dahkki: Daniel C. Baumgart (846351)
Almmustuhtton: (2016)

Combination of galectins-1 and -3 and CRP in active and inactive UC and CD.
Dahkki: Tony B. Yu (8292684)
Almmustuhtton: (2020)

Association results of tagging SNPs and MEFV exon 2 coding SNPs in the UC sample sets.
Dahkki: Alexandra-Chloé Villani (259241)
Almmustuhtton: (2009)

Latency of diagnosis (median; months) and interquartile range (IQR; months) of Inflammatory Bowel Disease (IBD) in age groups and by gender.
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)

Increasing number of IBD patients in Leipzig/Saxony.
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)

Fig 2 -
Dahkki: Ivana Kern (9936944)
Almmustuhtton: (2021)